Qilin pills prevent ovarian hyperstimulation syndrome of patients after IVF-ET by regulating plasma-related indicators

doi:10.12092/j.issn.1009-2501.2020.02.012

Abstract

Abstract: AIM: To study the preventive effect of Qilin pill on ovarian hyperstimulation syndrome (OHSS) after in vitro fertilization and embryo transfer (IVF-ET) and its effects on vascular endothelial growth factor (VEGF), tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in plasma. METHODS: Sixty-four patients undergoing IVF-ET treated in our hospital from January 2016 to January 2019 were selected. On the day of ovulation induction injection of human chorionic gonadotropin (HCG), 32 patients with high risk factors of OHSS were randomly divided into two groups. The control group received western medicine therapy, while the observation group received extra Qilin pill. The incidence of mild to moderate OHSS, fresh cycle transplant cancellation rate, plasma VEGF, TF, TFPI levels, and clinical outcomes of patients undergoing IVF-ET (HCG positive rate, biochemical pregnancy rate, clinical pregnancy rate) were compared between the two groups.RESULTS:There was no severe OHSS occurred in the two groups, the incidence of OHSS in the observation group (12.50%) and the cancellation rate of fresh cycle transplantation (15.63%) were lower than those in the control group (50.00%, 43.75%)（χ2=6.063,P=0.014）;The levels of VEGF and TF in the observation group on the day of egg retrieval and embryo transfer were ［(368±103) pg/mL, (392±91) pg/mL］,［(24±4)pg/ mL,(29±4) pg/mL］, which were lower than the control group ［(436±117) pg/mL, (448±108) pg/mL］,［(26±4) pg/mL, (31±4) pg/mL］ (t=2.450,2.237,4.093,5.204,P=0.017,0.029,＜0.001,＜0.001);The plasma TFPI levels in the observation group on the day of egg retrieval and embryo transfer were ［(73±18) ng/mL,(66±12) ng/mL］, higher than the control group ［(62±16）ng/mL, (58±10) ng/mL］(t=2.550,3.032,P=0.014,0.004);The biochemical pregnancy rate in the observation group (8.70%) was lower than that in the control group (42.86%) (χ2=4.147, P=0.042),the clinical pregnancy rate (91.30%) was higher than that of the control group (57.14%) (χ2=4.147,P=0.042).CONCLUSION:Qilin pill can prevent the occurrence of severe OHSS after IVF-ET, reduce the occurrence of mild to moderate OHSS, decrease the cancellation rate of fresh cycle transplantation and improve the pregnancy outcome after IVF-ET; Its mechanism may be related to the regulation of the expression of VEGF, TF and TFPI.

Key words: Qilin pill, ovarian hyperstimulation syndrome, vascular endothelial cell growth factor, IVF-ET surgery, tissue factor, tissue factor pathway inhibitor

CLC Number:

R984

LIU Hongdan, YIN Yihong. Qilin pills prevent ovarian hyperstimulation syndrome of patients after IVF-ET by regulating plasma-related indicators[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 196-202.

References

［1］Miller I, Chuderland D, Grossman H, et al. The dual role of PEDF in the pathogenesis of OHSS: negating both angiogenic and inflammatory pathways［J］.J Clin Endocrinol Metab, 2016,101(12):4699-4709.
［2］Gao J, Gu F, Miao BY, et al. Effect of the initiation of progesterone supplementation in in vitro fertilization-embryo transfer outcomes: a prospective randomized controlled trial［J］.Fertil Steril,2018,109(1):97-103.
［3］Zhang HF, Zhao J. Testicular artery-sparing microscopic varicocelectomy combined with Qilin Pills for bilateral varicocele-induced oligoasthenospermia［J］.Zhonghua Nan Ke Xue,2016,22(10):902-905.
［4］周延春.麒麟丸联合氯米芬治疗多囊卵巢综合征不孕的疗效及对患者血清激素水平的影响［J］.河北医药,2018,40(4):570-573.
［5］张玉珍.中医妇产学［M］.北京:中国中医药出版社,2005:320.
［6］王海燕,李北氢,李跃红.拮抗剂方案与标准长方案用于多囊卵巢综合征患者体外受精-胚胎移植妊娠结果分析［J］.国际生殖健康/计划生育杂志,2018,37(3):201-204.
［7］Cheng X, Zhai J, Liu J, et al. Zinc finger gene 217 (ZNF217) Promoted Ovarian Hyperstimulation Syndrome (OHSS) through Regulating E2Synthesis and Inhibiting Thrombospondin-1 (TSP-1)［J］.Sci Rep,2017,7(1):3245.
［8］Iltemir Duvan ZC, Naml Kalem M, Onaran Y, et al. The Effect of Coasting on Intracytoplasmic Sperm Injection Outcome in Antagonist and Agonist Cycle［J］.Int J Fertil,2017,11(1):1-6.
［9］Bushaqer NJ, Dayoub NM, Alhattali KK, et al.Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention［J］.Saudi Med J,2018,39(3):290-295.
［10］Lawrenz B, Ruiz F, Engelmann N, et al. Individual luteolysis post GnRH-agonist-trigger in GnRH-antagonist protocols［J］.Gynecol Endocrinol,2017,33(4):261-264.
［11］Gurbuz AS, Deveer R, Ozcimen N, et al. Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases［J］.Gynecol Endocrinol,2016,32(1):18-20.
［12］Mao JM, Jiang H, Wang CH, et al. Qilin Pills for idiopathic oligoasthenospermia: A multi-centered randomized double-blind controlled clinical trial［J］.Zhonghua Nan Ke Xue,2017,23(3):251-255.
［13］Zhang K, Ge Z, Fu L, et al.Qilin pills alleviate oligoasthenospermia by inhibiting Bax-caspase-9 apoptosis pathway in the testes of model rats［J］.Oncotarget,2018,9(31):21770-21782.
［14］张开舒,周芳,安琪,等.麒麟丸对少弱精子症模型雄性大鼠生殖功能的保护作用研究［J］.中华男科学杂志,2017,23(9):821-827.
［15］黄雪坤,冯月枝,黄永汉.麒麟丸联合人绝经期促性腺激素治疗未破裂卵泡黄素化综合征的疗效研究［J］.中国现代医学杂志,2016,26(9):114-117.
［16］贺玲,黄雪坤,冯月枝,等.麒麟丸联合芬吗通对薄型子宫内膜厚度、血流和妊娠率的影响［J］.生殖与避孕,2016,36(2):95-99.
［17］Inal HA, Inal ZO, Yilmaz N, et al. The effects of formoterol on the serum, peritoneal VEGF, MDA, and VEGF levels in the ovaries and endometrium of rats with OHSS［J］.Clin Exp Obstet Gynecol,2017,44(1):122-128.
［18］Zhai J, Liu J, Zhao S, et al.Kisspeptin-10 inhibits OHSS by suppressing VEGF secretion［J］.Reproduction,2017,154(4):355-362.
［19］Irani M, Seifer DB, Grazi RV, et al. Vitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled Trial［J］.Nutrients,2016,106(3):e252.
［20］焦静雅,仲立儒,杨方方,等.血栓弹力图检测在卵巢过度刺激综合征中的应用［J］.现代生物医学进展,2018,18(3):493-495,513.
［21］杨树花,邱晓晓,程蕾,等.滋阴抑亢调冲汤对卵巢过度刺激综合征(OHSS)大鼠凝血纤溶系统的影响［J］.中华中医药学刊,2016,34(5):1183-1185.

[1]	YAN Yuan-liang, GONG Zhi-cheng. Effects of polymorphisms in follicle stimulating hormone receptor genes on female reproductive function [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 944-949.
[2]	YANG Hai-yan, ZHAO Jun-zhao, LIN Wen-qin, LIN Jin-ju, RU Rong. Comparison of prednisone versus hydroxyethylstarch for prevention of moderate and severe ovarian hyperstimulation syndrome [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(6): 652-656.
[3]	WU Xu-bin, QIAN Zong-jie, WU Guang-wei, LIN Ying-zhong, HU Chang-xin. Effects of rosiglitazone on the synthesis of tumor necrosis factor-alpha and tissue factor in peripheral blood monouclear cells from patients with acute coronary syndrome without diabetes [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(2): 180-185.
[4]	WU Xu-bin, TANG Sheng-xin, WU Guang-wei, LIN Ying-zhong, HU Chang-xin. Effects of atorvastain on tissue factor and tumor necrosis factor-alpha synthesis in peripheral blood monocytes from patients with acute coronary syndrome [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 98-102.
[5]	XIA Li-juan, CHEN Fei-hu, HUANG Xue-ying, LIU Yong-jing, LI Jun. Effect of recombinant human endostatin on expression of vascular endothelial cell growth factor in adjuvant arthritis synovium tissue [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(7): 760-763.
[6]	CHEN Xiao-Yan, LI Ping, GUO Jiang-Hua, FENG Li-Ying, LI Jin-Hong. Clinical efficacy of short-effect GnRH-a for triggering ovulation on preventing ovarian hyperstimulation syndrome [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(7): 820-823.